70 compounds | Property logBB: The ratio of brain−blood partitioning as logBB
ID | Name | logBB | Ref | Details |
---|---|---|---|---|
Tab1_1 | cimetidine | -1.42 | [1] | View |
Tab1_2 | N-(4-methyl-1,3-thiazol-2-yl)guanidine | -0.04 | [1] | View |
Tab1_3 | icotidine | -2 | [1] | View |
Tab1_4 | 2-[[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]amino]-5-(2-naphthalenylmethyl)-4(3H)-pyrimidinone | -1.3 | [1] | View |
Tab1_5 | lupitidine | -1.06 | [1] | View |
Tab1_6 | N-(2,6-dichlorophenyl)-2,5-dihydro-1H-imidazol-2-amine | 0.11 | [1] | View |
Tab1_7 | mepyramine | 0.49 | [1] | View |
Tab1_8 | imipramine | 0.83 | [1] | View |
Tab1_9 | ranitidine | -1.23 | [1] | View |
Tab1_10 | tiotidine | -0.82 | [1] | View |
Tab1_11 | 4-(3-Amino-1H-1,2,4-triazol-5-yl)-N,N-dimethylpyridin-2-amine | -1.17 | [1] | View |
Tab1_12 | N-[2-[[(3-Bromo-2-pyridinyl)methyl]thio]ethyl]-N'-cyano-N''-ethylguanidine | -2.15 | [1] | View |
Tab1_13 | N-(2-{[(3-Bromopyridin-2-yl)methyl]sulfanyl}ethyl)-3-nitro-1H-pyrrol-2-amine | -0.67 | [1] | View |
Tab1_14 | 1H-Pyrrol-2-amine, 3-nitro-N-[2-[(2-pyridinylmethyl)thio]ethyl]- | -0.66 | [1] | View |
Tab1_15 | 3-Nitro-4-(phenylmethyl)-N-[2-[(2-pyridinylmethyl)thio]ethyl]-1H-pyrrol-2-amine | -0.12 | [1] | View |
Tab1_16 | guanidine, N''-(4-phenyl-2-thiazolyl)- | -0.18 | [1] | View |
Tab1_17 | 4-(3-Aminophenyl)-2-guanidinothiazole | -1.15 | [1] | View |
Tab1_18 | N-[3-(2-Carbamimidamido-1,3-thiazol-4-yl)phenyl]acetamide | -1.57 | [1] | View |
Tab1_19 | 1-[3-(2-Carbamimidamido-1,3-thiazol-4-yl)phenyl]-2-cyano-3-methylguanidine | -1.54 | [1] | View |
Tab1_20 | N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-3-nitro-1H-pyrrol-2-amine | -1.12 | [1] | View |
Tab1_21 | N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-3-nitro-4-(phenylmethyl)-1H-pyrrol-2-amine | -0.73 | [1] | View |
Tab1_22 | N-[3-[5-[(Dimethylamino)methyl]-2-furanyl]phenyl]-3-nitro-1H-pyrrol-2-amine | -0.27 | [1] | View |
Tab1_23 | N,N-Dimethyl-2-[3-[(3-nitro-1H-pyrrol-2-yl)amino]phenyl]-4-pyridinemethanamine | -0.28 | [1] | View |
Tab1_24 | Acetamide, N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]- | -0.46 | [1] | View |
Tab1_25 | Benzamide, N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]- | -0.24 | [1] | View |
Tab1_26 | 1-Propanol, 3-[3-(1-piperidinylmethyl)phenoxy]- | -0.02 | [1] | View |
Tab1_27 | 2-Pyridinamine, N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]- | 0.69 | [1] | View |
Tab1_28 | N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]-2-thiazolamine | 0.44 | [1] | View |
Tab1_29 | zolantidine | 0.14 | [1] | View |
Tab1_30 | N-(3-{3-[(Piperidin-1-yl)methyl]phenoxy}propyl)-1,3-benzoxazol-2-amine | 0.22 | [1] | View |
Tab1_31 | butanone | -0.08 | [1] | View |
Tab1_32 | benzene | 0.37 | [1] | View |
Tab1_33 | 3-methylpentane | 1.01 | [1] | View |
Tab1_34 | 3-methylhexane | 0.9 | [1] | View |
Tab1_35 | 2-propanol | -0.15 | [1] | View |
Tab1_36 | 2-methylpropanol | -0.17 | [1] | View |
Tab1_37 | 2-methylpentane | 0.97 | [1] | View |
Tab1_38 | 2,2-dimethylbutane | 1.04 | [1] | View |
Tab1_39 | 1,1,1-trifluoro-2-chloroethane | 0.08 | [1] | View |
Tab1_40 | 1,1,1-trichloroethane | 0.4 | [1] | View |
Tab1_41 | diethyl ether | 0 | [1] | View |
Tab1_42 | enflurane | 0.24 | [1] | View |
Tab1_43 | ethanol | -0.16 | [1] | View |
Tab1_44 | fluroxene | 0.13 | [1] | View |
Tab1_45 | 3-Bromo-3-chloro-1,1,1-trifluoropropane | 0.35 | [1] | View |
Tab1_46 | heptane | 0.81 | [1] | View |
Tab1_47 | hexane | 0.8 | [1] | View |
Tab1_48 | isoflurane | 0.42 | [1] | View |
Tab1_49 | methane | 0.04 | [1] | View |
Tab1_50 | methylcyclopentane | 0.93 | [1] | View |
Tab1_51 | nitrogen | 0.03 | [1] | View |
Tab1_52 | pentane | 0.76 | [1] | View |
Tab1_53 | propanol | -0.16 | [1] | View |
Tab1_54 | propanone | -0.15 | [1] | View |
Tab1_55 | teflurane i | 0.27 | [1] | View |
Tab1_56 | toluene | 0.37 | [1] | View |
Tab1_57 | trichloroethene | 0.34 | [1] | View |
Tab2_1 | betahistine i | -0.3 | [2] | View |
Tab2_2 | 2-Pyridineethanamine, N,N-dimethyl- i | -0.06 | [2] | View |
Tab2_3 | 2-thiazoleethanamine i | -0.42 | [2] | View |
Tab2_4 | 2-(4-phenyl-1,3-thiazol-2-yl)ethanamine i | -1.3 | [2] | View |
Tab2_5 | Imidazo[1,2-a]pyridine-2-ethanamine i | -1.4 | [2] | View |
Tab2_6 | 4-[2-(Dipropylamino)ethyl]-7-hydroxy-1,3-dihydro-2H-indol-2-one i | -0.43 | [2] | View |
Tab2_7 | ropinirole i | 0.25 | [2] | View |
Tab3_1 | Amizepin | 0 | [1] | View |
Tab3_2 | 10,11-Epoxycarbamazepine | -0.34 | [1] | View |
Tab3_3 | 6H-imidazo[1,5-a][1,4]benzodiazepin-6-one, 7-chloro-4,5-dihydro-5-methyl-3-[5-(1-methylethyl)-1,2,4-oxadiazol-3-yl]- | -0.3 | [1] | View |
Tab3_4 | 7-Chloro-4,5-dihydro-3-[5-(1-hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one | -1.34 | [1] | View |
Tab3_5 | 7-Chloro-3-[5-(1,2-dihydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-4,5-dihydro-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one | -1.82 | [1] | View |
Tab3_6 | Amitriptyline | 0.76 | [1] | View |
Lombardo, F.; Blake, J. F.; Curatolo, W. J. Computation of Brain−Blood Partitioning of Organic Solutes via Free Energy Calculations. J. Med. Chem. 1996, 39, 4750–4755. https://doi.org/10.1021/jm960163r
Abraham, M.; Chadha, H.; Mitchell, R. Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. Drug Des. Discovery 1995, 13, 123—131.